Lv41
620 积分 2024-01-11 加入
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
2小时前
待确认
Cisplatin plus etoposide versus other platin‐based regimens for patients with extensive small‐cell lung cancer: a systematic review and meta‐analysis of randomised, controlled trials
10天前
已完结
Relationship between the tumor microenvironment and the efficacy of the combination of radiotherapy and immunotherapy
10天前
已完结
Thoracic radiotherapy plus maintenance durvalumab after first line carboplatin and etoposide plus durvalumab in extensive-stage disease small cell lung cancer (ES-SCLC) – A multicenter single arm open label phase II trial (SAKK 15/19)
24天前
已完结
[Expert consensus on diagnosis and treatment of advanced non-small cell lung cancer with HER-2 alterations (2025 edition)]
1个月前
已完结
靶向HER2 的抗体药物偶联物应用进展
1个月前
已完结
Real‐world efficacy and safety of ritlecitinib in alopecia areata: A single‐centre experience
1个月前
已完结
Comparison and quantification of different concurrent chemotherapy regimens with radiotherapy in locally advanced non-small cell lung cancer: Clinical outcomes and theoretical results from an extended LQ and TCP model
3个月前
已完结
Zongertinib in Previously Treated HER2 -Mutant Non–Small-Cell Lung Cancer
4个月前
已完结
Small Cell Lung Cancer: A Review
5个月前
已完结
皖公网安备34019202002308
